Gordon J. Coburn
Analyst · JPMorgan
Thank you, Francisco. Although we had to reduce our full year growth expectations, due primarily to the performance of our core Horizon 1 businesses, it's very important to keep in perspective that these businesses are still extraordinarily healthy, as demonstrated by our continued industry-leading growth. We believe that the market for our Horizon 1 and 2 businesses is under-penetrated, which provides a strong -- which provides strong opportunities for continued growth, and that our unique financial model, global delivery network and intimate client relationships positions us to capture an outsized share of that market. The longer-term demand environment remains strong. We are helping clients navigate secular shifts in their industries while at the same time driving more efficient and effective operations. For Horizon 1 services, we continue to see broad opportunities to expand our global delivery model. Our clients continue to turn to us to help drive greater levels of productivity through best-in-class methodologies. At the same time, the dual mandate of driving both operational efficiencies and innovation has resulted in a notable increase in large transformational deals across our business. Clients are reinvesting savings generated from these cost-optimizing programs into initiatives that will enable them to rethink their business model, rewire operations or reexamine which activities are core to their competitive edge versus which would have been -- which would be better handled by a partner like Cognizant with deeper, more scalable expertise. From a demand standpoint, this is creating newer opportunities for partnership with our clients across multiple service lines. Within Horizon 2, our addressable market is expanding, particularly within the BPO area. Our core BPO offerings continue to show solid growth, supported by expansion of work with existing clients and recent wins with new clients. The vertical focus of our BPO practice based on deep knowledge of the industries we serve, coupled with the ability to deliver value via wage arbitrage, productivity improvements and technology-enabled modernization and automation drives our competitive strength. This is evidenced in some of our most recent wins, including several multiyear deals with major healthcare payer firms to provide claims processing, enrollment and several other industry-aligned services. We've also added another multiyear deal involving the delivery of clinical data management and drug safety services, this time for our pharmaceutical firm in Asia-Pacific. Within ITIS, we continue to focus on scaling across industries and clients. ITIS is becoming more mainstream as clients continue to adopt the global delivery model, which is fueling "higher than company average" growth in the space. Q1 brought us some key wins in the space, particularly in Financial Services and Healthcare. Of note, we won a key ITIS deal with a Scandinavian financial services client this quarter. Growing interest in ITIS projects has kept our pipeline robust. Cognizant Business Consulting continues to grow faster than the company average. We continue to see a growing interest in large-scale IT and business transformation work as well as cost optimization projects. Importantly, as recognized by industry analysts, we have built a strong upstream consulting organization focused on delivering value-added consulting. To illustrate, we recently won an assignment with a major retailer to analyze the current state of multichannel operations, store operations, merchandising and ERP and create a roadmap for business transformation. Additionally, for a top 10 insurer, we are defining the future functional state of their customer relationship landscape. Now let me shift to an industry view of our business. In Financial Services, which includes our banking and insurance clients, we saw mixed results between these 2 subsectors, particularly in North America. Our overall banking sector remained flat during the quarter. This was driven primarily by softness among our top North American backing clients. While we expect our banking sector to grow in 2012, the pace of growth will certainly be slower than we expected 3 months ago. This is especially true among our large North American clients, where there remains a heightened focus on cost optimization due to the macroeconomic and regulatory pressures which are driving fundamental changes in their business models. As a result, their IT spend acceleration with us is not as strong as we originally anticipated and as many of them indicated at the beginning of the year. Among these larger clients, there's a slower ramp in discretionary projects. Interestingly, the same industry dynamics are resulting in robust growth among our midsized banking clients. Generally, these clients are not as far along in their transition to a global delivery model, and the industry pressures are serving as a catalyst to accelerate this transition. Our insurance customers saw a strong growth of 6% in the first quarter, and we expect continued solid growth both in Q2 and for the rest of the year. Across insurance, we continue to consolidate positions with existing clients and added several new logos this quarter. As such, our insurance pipeline remains healthy. Within healthcare, it's another mixed story. Our pharmaceutical business declined 4% sequentially in Q1, while the payor side of healthcare grew 7%. To some extent, the softness in the first quarter for the pharmaceutical industry is a normal seasonal pattern. However, the Q1 weakness was more pronounced this year than in prior years. The industry continues to go through a significant transformation due to the large number of drugs coming off patent. The pullback on discretionary spend as a result of this patent cliff has had a more significant impact on our rate of growth in this industry than we anticipated 90 days ago as we see our pharma clients underspend their original plans for the year. Our revenue mix in the pharma industry is more weighted towards discretionary work than our overall company mix. Therefore the slower-than-anticipated revenue discretionary spend is impacting us. We expect our growth rate for this subsector to lag the overall company growth rate in Q2 and for the rest of the year. Meanwhile, the payor side of healthcare continues to be driven by changes in the regulatory environment. It grew 7% sequentially in Q1. We continue to see an increased number of large-scale complex transformational opportunities in this space. Moving to our performance by geography. As I just highlighted in our Q1 North America performance, we saw sluggishness in banking and life sciences. Excluding these subsectors, business is generally playing out as expected, with clients increasing spend on both cost-containment and innovation-related initiatives. Despite protracted economic issues, which constrained spending by some clients and increased demand for cost containment by others, European revenue grew 3.5% sequentially and 11% year-over-year. We had several significant wins during the quarter, including a large SAP program for a U.K. utility company, a managed-services-based application outsourcing engagement for a French life sciences company and a large enterprise application development and maintenance program for a major consumer goods company. While we did have a solid quarter in Europe, our expectations remained cautious in the short term for this market. However, as we have stated before, Europe remains an attractive long-term market for us. After all, the overall European IT services market is roughly the same size as the North American IT services market. Yet the penetration of the global delivery model in Europe is currently a fraction of that in North America. As such, we believe Europe merits our continued focus and investment. In particular, we continue to focus on building local teams on the ground across key markets in Europe to address the specific needs of European clients. We are also systematically ensuring that we have the capability to deliver the full range of Cognizant service offerings in discrete European markets to meet client demand. Despite representing a small revenue share, we were very pleased with the strong growth in Asia-Pacific and rest of the world, which grew 7% sequentially and 47% year-over-year. Growth in the sector was driven by a few key wins in some of our high-growth service areas, like ITIS, such as our recent win with a large global bank to provide IP infrastructure and application support across all critical areas of the bank from 3 different global locations. This program, which is designed and delivered as a utility service across the bank, emphasizes a strong transformational agenda which is targeted at optimizing costs while enhancing the end user experience. I will now hand the call over to Karen to comment on our financial performance and guidance. Karen?